Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Cash & Current Investments (2015 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Cash & Current Investments of $10.1 million for Q1 2026, down 39.99% year-over-year from $16.9 million in Q1 2025, and down 57.76% quarter-over-quarter from $24.0 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Cash & Current Investments (2015 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Cash & Current Investments for 11 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Current Investments fell 39.99% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $10.1 million (down 39.99% YoY), while the FY2025 annual figure was $24.0 million, down 4.35% from the prior year.
  • Cash & Current Investments eased to $10.1 million in Q1 2026 per SLGL's latest filing, from $24.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $42.2 million in Q2 2022 and bottomed at $6.7 million in Q3 2025.
  • Historically, Cash & Current Investments has averaged $20.3 million across 5 years, with a median of $21.1 million in 2022.
  • On a YoY basis, Cash & Current Investments climbed as much as 68.07% in 2022 and fell as far as 80.39% in 2022.
  • Sol-Gel Technologies' Cash & Current Investments stood at $21.1 million in 2022, then soared by 32.46% to $28.0 million in 2023, then decreased by 14.54% to $23.9 million in 2024, then climbed by 0.36% to $24.0 million in 2025, then tumbled by 57.76% to $10.1 million in 2026.
  • Business Quant data shows SLGL's Cash & Current Investments at $10.1 million in Q1 2026, $24.0 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 47.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.93 Mn
Mar 31, 2026 52.83 Mn
Dec 31, 2025 24.00 Mn
Sep 30, 2025 6.72 Mn
Jun 30, 2025 20.68 Mn
Mar 31, 2025 16.90 Mn
Dec 31, 2024 23.91 Mn
Sep 30, 2024 28.05 Mn
Jun 30, 2024 27.62 Mn
Mar 31, 2024 16.22 Mn
Dec 31, 2023 27.98 Mn
Sep 30, 2023 26.14 Mn
Jun 30, 2023 30.29 Mn
Mar 31, 2023 15.31 Mn
Dec 31, 2022 21.13 Mn
Sep 30, 2022 25.50 Mn
Jun 30, 2022 42.24 Mn
Mar 31, 2022 30.25 Mn
Dec 31, 2021 21.79 Mn
Sep 30, 2021 45.59 Mn